[Taylor&Francis] Nephrotoxicity risks of colistin-combination therapy: a USFDA adverse event reporting system analysis using disproportionality and interaction assessment

minh1342 Post time 3 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-25 01:37
Reward30points

journalㄩExpert Opinion on Drug Safety

AuthorsㄩKannan Sridharan

Published dateㄩ--

DOIㄩ10.1080/14740338.2025.2499672

PDF linkㄩhttps://www.tandfonline.com/doi/pdf/10.1080/14740338.2025.2499672

Article linkㄩhttps://doi.org/10.1080/14740338.2025.2499672

Article SourceㄩInforma UK Limited


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Abs33 Post time 3 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list